Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS Research and Therapy
Published in: AIDS Research and Therapy 1/2016

Open Access 01-12-2016 | Review

Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis

Authors: Akosua Adom Agyeman, Richard Ofori-Asenso

Published in: AIDS Research and Therapy | Issue 1/2016

Login to get access

Abstract

Background

Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection has been associated with higher morbidity and mortality and may impact significantly on healthcare resource utilization. However, in Ghana, accurate estimates of the prevalence of HIV/HBV coinfection needed to inform policy decisions and the design of public health interventions are currently lacking. In this study, our aim was to determine the HIV/HBV coinfection prevalence rate in Ghana.

Methods

Primary studies reporting prevalence of HIV/HBV coinfection in Ghana were retrieved through searches conducted in PubMed, science direct, Google scholar and Africa journals online (AJOL) databases. The websites of the Ministry of Health and Ghana Health Service were also searched for related reports or reviews. Additionally, the online repository of two leading Ghanaian universities were searched to identify unpublished thesis related to the subject. All online searches were conducted between 01/03/2016 and 12/03/2016. Further searches were conducted through reference screening of retrieved papers.

Results

Twelve (12) studies published between 1999 and 2016 and conducted across seven (7) regions of Ghana were included in this review. The three (3) regions with no studies’ representation were Upper East, Upper West and Central regions. The 12 included studies involved a total of 8162 HIV patients. The reported HIV/HBV coinfection prevalence rates ranged from 2.4 to 41.7 %. The pooled HIV/HBV coinfection prevalence rate was determined as 13.6 % (95 % CI 10.2–16.8 %; P < 0.001).

Conclusions

In Ghana, about one in seven HIV patients may be also be chronically infected with HBV. Preventive interventions and strategic policy directions including systematic screening of all newly diagnosed HIV cases for coinfection will be needed, so as to improve management strategies for HBV infection and antiretroviral therapy (ART) implementation.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM. HIV/HBV coinfections: epidemiology, natural history, and treatment: a review article. Iran Red Crescent Med J. 2011;13(12):855–62.PubMedPubMedCentral
4.
5.
Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18:2039–45.CrossRefPubMed
6.
Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol. 2006;44(1 Suppl):S65–70.CrossRefPubMed
7.
Thio CL, Seaberg EC, Skolasky RL, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multi-Center AIDS Cohort Study (MACS). Lancet. 2002;360:1921–6.CrossRefPubMed
8.
Gatanaga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S. Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis. 2000;19:237–9.CrossRefPubMed
9.
Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009;48:1763–71.CrossRefPubMed
10.
Owolabi LF, Ibrahim A, Musa BM, Gwaram BA, Dutse AI, et al. Prevalence and burden of human immunodeficiency virus and hepatitis B virus coinfection in Nigeria: a systematic review and meta-analysis. J AIDS Clin Res. 2014;5:308.CrossRef
11.
Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa. J Clin Virol. 2014;61(1):20–33.CrossRefPubMed
12.
Matthews GV, Manzini P, Hu Z, Khabo P, Maja P, Matchaba G, et al. Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. AIDS. 2011;25:1727–35.CrossRefPubMed
13.
Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):e1024–31.CrossRefPubMed
14.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9 (w64).CrossRefPubMed
15.
Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol. 2005;16(2):65–72.PubMedPubMedCentral
16.
Ofori-Asenso R, Agyeman A. Hepatitis B in Ghana: a systematic review and meta-analysis of prevalence studies (1995–2015). BMC Infect Dis. 2016;16(1):130.CrossRefPubMedPubMedCentral
17.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.CrossRefPubMedPubMedCentral
18.
Wallace Byron C, Dahabreh Issa J, Trikalinos Thomas A, Lau Joseph, Trow Paul, Schmid Christopher H. Closing the Gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012;49:5.CrossRef
19.
20.
21.
22.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.CrossRefPubMed
23.
Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–60.CrossRefPubMed
24.
Brandful JA, Apeagyei FA, Ampofo WK, Adu-Sarkodie Y, Ansah JE, Nuvor V, Aidoo S, Ishikawa K, Sata T, Yamamoto N, Yamazaki S. Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana. Viral Immunol. 1999;12(2):131–7.CrossRefPubMed
25.
Apea-Kubi KA, Yamaguchi S, Sakyi B, Ofori-Adjei D. HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana. West Afr J Med. 2006;25(1):17–21.PubMed
26.
Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, Garcia A, Phillips RO. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol. 2010;48(9):3223–30.CrossRefPubMedPubMedCentral
27.
Cho Y, Bonsu G, Akoto-Ampaw A, Nkrumah-Mills G, Nimo JJ, Park JK, Ki M. The prevalence and risk factors for hepatitis B surface Ag positivity in pregnant women in eastern region of Ghana. Gut Liver. 2012;6(2):235–40.CrossRefPubMedPubMedCentral
28.
Kubio C, Tierney G, Quaye T, Nabilisi JW, Ziemah C, Zagbeeb SM, Shaw S, Murphy WG. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Transfusion. 2012;52(10):2161–6.CrossRefPubMed
29.
Gye-Duodu K. Prevalence of hepatitis B virus coinfection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. Accra: University of Ghana, School of Public Health; 2012 (Unpublished dissertation).
30.
Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA. Prevalence and impact of hepatitis B and C virus coinfections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana. J Med Virol. 2012;84(1):6–10.CrossRefPubMed
31.
Walana W, Ahiaba S, Hokey P, Vicar EK, Acuqah SEK, Der EM, Ziem TB. Sero-prevalence of HIV, HBV and HCV among blood donors in the Kintampo Municipal Hospital, Ghana. Br Microbiol Res J. 2014;4(12):1491–9.CrossRef
32.
Anyimah IO. Biochemical and haematological responses of HIV patients co-infected with hepatitis B virus and hepatitis C virus to antiretroviral therapy. Kumasi: Kwame Nkrumah Univeristy of Science and Technology; 2009 (Unpublished dissertation).
33.
King S, Adjei-Asante K, Appiah L, Adinku D, Beloukas A, Atkins M, Sarfo SF, Chadwick D, Phillips RO, Geretti AM. Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana. J Viral Hepat. 2015;22(5):461–8.CrossRefPubMed
34.
Stockdale AJ, Phillips RO, Beloukas A, Appiah LT, Chadwick D, et al. Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus coinfection in Ghana. Clin Infect Dis. 2015;61(6):883–91.CrossRefPubMed
35.
Archampong TN, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Gillani FS, Yang H, Boamah I, Flanigan T, Kwara A. Proportion and factors associated with hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients. BMC Infect Dis. 2016;16(1):14.CrossRefPubMedPubMedCentral
36.
Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002;9(4):243–57.CrossRefPubMed
37.
38.
Lacombe K, Bottero J, Lemoine M, Boyd A, Girard PM. HIV/hepatitis B virus coinfection: challenges and new strategies. J Antimicrob Chemother. 2010;65(1):10–7.CrossRefPubMed
39.
Noubiap JJ, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN. Hepatitis B and C coinfections in some HIV-positive populations in Cameroon, West Central Africa: analysis of samples collected over more than a decade. PLoS ONE. 2015;10(9):e0137375.CrossRefPubMedPubMedCentral
40.
Blankson A, Wiredu EK, Adjei A, Tettey Y. Seroprevalence of hepatitis B and C viruses in cirrhosis of the liver in Accra, Ghana. Ghana Med J. 2005;39(4):132–7.PubMedCentral
41.
Mutocheluh M, Kwarteng K. Knowledge and occupational hazards of barbers in the transmission of hepatitis B and C was low in Kumasi, Ghana. Pan Afr Med J. 2015;20:260.CrossRefPubMedPubMedCentral
42.
Akumiah PO, Sarfo LA. Knowledge and practices of certified barbers about hepatitis B and C transmission in Kumasi, Ghana. Appl Res J. 2015;1(2):27–35.
43.
44.
Metadata
Title
Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis
Authors
Akosua Adom Agyeman
Richard Ofori-Asenso
Publication date
01-12-2016
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2016
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-016-0107-x

Other articles of this Issue 1/2016

AIDS Research and Therapy 1/2016 Go to the issue

Research

Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study

Research

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

Research

Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections

Review

Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US

Research

Predictors of perceived male partner concurrency among women at risk for HIV and STI acquisition in Durban, South Africa

Research

Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits